Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension.
CONCLUSIONS: In this real-world data analysis, patients using droxidopa without concomitant medications for OH were more likely to remain on treatment than patients on midodrine.
PMID: 32200263 [PubMed - as supplied by publisher]
Source: Autonomic Neuroscience - Category: Neuroscience Authors: Kymes SM, Sullivan C, Jackson K, Raj SR Tags: Auton Neurosci Source Type: research
More News: Brain | Databases & Libraries | Insurance | Neurology | Neuroscience | Study | USA Health